157 related articles for article (PubMed ID: 2825895)
1. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus C; Mistry R; Maisey MN
Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
[TBL] [Abstract][Full Text] [Related]
2. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
[No Abstract] [Full Text] [Related]
3. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
[TBL] [Abstract][Full Text] [Related]
4. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
[No Abstract] [Full Text] [Related]
5. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
[No Abstract] [Full Text] [Related]
6. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
[No Abstract] [Full Text] [Related]
7. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
Guerra U; Pizzocaro C; Terzi A; Giubbini R; Bestagno M
J Nucl Med Allied Sci; 1988; 32(4):242-7. PubMed ID: 2852709
[No Abstract] [Full Text] [Related]
8. Technetium-99m pentavalent DMSA imaging detects metastases of poorly differentiated carcinoma of the thyroid.
Costa DC; Glynne-Jones R; Falzon M; Lui D; Ryder JP; Ell PJ
Clin Nucl Med; 1989 Mar; 14(3):218-21. PubMed ID: 2544341
[No Abstract] [Full Text] [Related]
9. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
[TBL] [Abstract][Full Text] [Related]
10. Experience in imaging medullary thyroid carcinoma using 99mTc (V) dimercaptosuccinic acid (DMSA).
Clarke S; Lazarus C; Maisey M
Henry Ford Hosp Med J; 1989; 37(3-4):167-8. PubMed ID: 2576956
[TBL] [Abstract][Full Text] [Related]
11. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
[No Abstract] [Full Text] [Related]
12. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
Mojiminiyi OA; Udelsman R; Soper ND; Shepstone BJ; Dudley NE
Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
[TBL] [Abstract][Full Text] [Related]
14. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
15. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
16. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Clarke SE; Lazarus CR; Maisey MN
Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
[TBL] [Abstract][Full Text] [Related]
18. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
[TBL] [Abstract][Full Text] [Related]
19. Preparation of 99Tcm (V) DMSA.
Sampson CB
Nucl Med Commun; 1987 Mar; 8(3):184-5. PubMed ID: 3035444
[No Abstract] [Full Text] [Related]
20. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
